Literature DB >> 26865454

A Critical Role of miR-144 in Diffuse Large B-cell Lymphoma Proliferation and Invasion.

Haiying Wang1, Aihong Wang1, Zhenbo Hu1, Xin Xu1, Zhiqiang Liu2, Zhanju Wang3.   

Abstract

MicroRNAs are endogenous noncoding RNAs that play important roles in a wide variety of biologic processes such as apoptosis, development, aging, and tumorigenesis. The B-cell lymphoma 6 (BCL6) transcriptional repressor has emerged as a critical therapeutic target in diffuse large B-cell lymphomas (DLBCL), but the mechanisms regulating BCL6 are still unclear. In the current study, we screened the microRNA expression profiles in DLBCL specimens and cell lines by qRT-PCR and found that the expression of miR-144 was significantly downregulated in DLBCL tissues and cell lines and negatively correlated with BCL6 expression. We further demonstrated that BCL6 was the direct target gene of miR-144, and miR-144 suppressed the expression of BCL6 via binding the 3'untranslated region of BCL6 mRNA. Biologically, forced expression of miR-144 significantly attenuated cell proliferation and invasion of OCI-Ly3 cells in vitro, and the tumor-suppressor effect of miR-144 was also confirmed using a xenograft mouse model in vivo Taken together, our results reveal that miR-144 regulates BCL6 in DLBCL and provide a rationale for developing strategies that target miR-144 as a therapeutic intervention for DLBCL. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26865454     DOI: 10.1158/2326-6066.CIR-15-0161

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  13 in total

1.  miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.

Authors:  Pingping Tao; Hao Wen; Binlie Yang; Ai Zhang; Xiaohua Wu; Qing Li
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

Review 2.  Dysregulated MicroRNA Expression Profiles and Potential Cellular, Circulating and Polymorphic Biomarkers in Non-Hodgkin Lymphoma.

Authors:  Gabrielle Bradshaw; Heidi G Sutherland; Larisa M Haupt; Lyn R Griffiths
Journal:  Genes (Basel)       Date:  2016-12-17       Impact factor: 4.096

3.  MicroRNA-144 is regulated by CP2 and decreases COX-2 expression and PGE2 production in mouse ovarian granulosa cells.

Authors:  Jiawei Zhou; Bin Lei; Huanan Li; Lihua Zhu; Lei Wang; Hu Tao; Shuqi Mei; Fenge Li
Journal:  Cell Death Dis       Date:  2017-02-09       Impact factor: 8.469

4.  MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma.

Authors:  Giorgio Malpeli; Stefano Barbi; Corinna Greco; Simonetta Zupo; Anna Bertolaso; Maria Teresa Scupoli; Mauro Krampera; Paul Takam Kamga; Carlo Maria Croce; Aldo Scarpa; Alberto Zamò
Journal:  Oncotarget       Date:  2018-04-13

5.  Activating and sustaining c-Myc by depletion of miR-144/451 gene locus contributes to B-lymphomagenesis.

Authors:  Lan Ding; Yanqing Zhang; Lingling Han; Lei Fu; Xia Mei; Jijun Wang; Jacobi Itkow; Afaf Elabid Ibrahim Elabid; Lei Pang; Duonan Yu
Journal:  Oncogene       Date:  2017-12-29       Impact factor: 9.867

6.  Identification of key candidate genes and miRNA‑mRNA target pairs in chronic lymphocytic leukemia by integrated bioinformatics analysis.

Authors:  Chundi Gao; Chao Zhou; Jing Zhuang; Lijuan Liu; Junyu Wei; Cun Liu; Huayao Li; Changgang Sun
Journal:  Mol Med Rep       Date:  2018-11-09       Impact factor: 2.952

7.  Long Non-Coding RNAs Modulate Sjögren's Syndrome Associated Gene Expression and Are Involved in the Pathogenesis of the Disease.

Authors:  Marzia Dolcino; Elisa Tinazzi; Claudio Vitali; Nicoletta Del Papa; Antonio Puccetti; Claudio Lunardi
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

Review 8.  MiR-144: A New Possible Therapeutic Target and Diagnostic/Prognostic Tool in Cancers.

Authors:  Omid Kooshkaki; Zohre Rezaei; Meysam Rahmati; Parviz Vahedi; Afshin Derakhshani; Oronzo Brunetti; Amir Baghbanzadeh; Behzad Mansoori; Nicola Silvestris; Behzad Baradaran
Journal:  Int J Mol Sci       Date:  2020-04-08       Impact factor: 5.923

9.  Identification of Recurrent Mutations in the microRNA-Binding Sites of B-Cell Lymphoma-Associated Genes in Follicular Lymphoma.

Authors:  Erika Larrea; Marta Fernandez-Mercado; José Afonso Guerra-Assunção; Jun Wang; Ibai Goicoechea; Ayman Gaafar; Izaskun Ceberio; Carmen Lobo; Jessica Okosun; Anton J Enright; Jude Fitzgibbon; Charles H Lawrie
Journal:  Int J Mol Sci       Date:  2020-11-20       Impact factor: 5.923

10.  MiR-144-3p-mediated dysregulation of EIF4G2 contributes to the development of hepatocellular carcinoma through the ERK pathway.

Authors:  Shuangshuang Li; Jiajia Shao; Guohua Lou; Chao Wu; Yanning Liu; Min Zheng
Journal:  J Exp Clin Cancer Res       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.